O
Otsuka
OrganizationHeard in 7 episodes across 5 shows since Aug 2026
A Japanese healthcare and pharmaceutical group that completed the acquisition of Transcend Therapeutics, including upfront and contingent consideration.
Discussed inMarkets100%
Episodes
7
across 5 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of Otsuka per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 26 | 0.01‰ | 1 |
| Sep 24 | 0.01‰ | 1 |
| Oct 30 | 0.01‰ | 1 |
| Nov 5 | 0.02‰ | 1 |
| Nov 6 | 0.03‰ | 3 |
| Nov 9 | 0.04‰ | 1 |
| Nov 13 | 0.02‰ | 1 |
Email alert
Email me when Otsuka comes up on a podcast
One email a week at most, with the new episodes that mention Otsuka. Free, no account needed, unsubscribe in one click.
Episodes
7 episodes featuring Otsuka, newest first
- Nov 13, 2026
Heart drug failures test genetics-led discoveryThe Readout LoudNov 13, 2026 - Nov 9, 2026
AbbVie builds a risk-managed neuroscience portfolioBusiness Of BiotechNov 9, 2026 - Nov 6, 2026
Election stakes meet biotech’s regulatory and pipeline risksBiotech HangoutNov 6, 2026 - Nov 5, 2026
Solvonis expands ketamine patent into behavioral addictionsThe Sunday RoastNov 5, 2026 - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026 - Sep 24, 2026
Kevin Ryan bets on durable trends over startup hypeThe Tim Ferriss ShowSep 24, 2026